Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH Replacement Dose Effect on CV Risk in GHD
NCT01877512Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2013
- Primary completion
- Apr 2014
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in growth hormone deficiency (GHD), sponsored by Amsterdam University Medical Center. Started May 2013; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01877512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01877512.